Your browser doesn't support javascript.
loading
The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma.
Schieven, Sebastiaan M; Traets, Joleen J H; Vliet, Alex V; Baalen, Martijn V; Song, Ji-Ying; Guimaraes, Marcos Da Silva; Kuilman, Thomas; Peeper, Daniel S.
Afiliação
  • Schieven SM; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Traets JJH; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Vliet AV; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Baalen MV; Division of Flow Cytometry Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Song JY; Division of Animal Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Guimaraes MDS; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Kuilman T; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Peeper DS; Division of Molecular Oncology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Mol Cancer Res ; 21(5): 428-443, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36753617
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquitina-Proteína Ligases / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ubiquitina-Proteína Ligases / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Cancer Res Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda